| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 3537- | 5-HTP, | 5-Hydroxytryptophan: a clinically-effective serotonin precursor |
| - | Review, | NA, | NA |
| 5309- | 5-HTP, | Effects of Carbidopa on the Cerebral Accumulation of Exogenous L-5-Hydroxytryptophan in Mice |
| 5298- | 5-HTP, | Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa |
| - | Human, | AD, | NA |
| 5291- | 5-HTP, | Kinetics of l-5-hydroxytryptophan in healthy subjects |
| - | in-vivo, | Nor, | NA |
| 5464- | AF, | Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies |
| - | vitro+vivo, | GBM, | NA |
| 5439- | AG, | Absorption enhancement study of astragaloside IV based on its transport mechanism in Caco-2 cells |
| - | in-vitro, | Colon, | Caco-2 |
| 5356- | AL, | Therapeutic role of allicin in gastrointestinal cancers: mechanisms and safety aspects |
| - | Review, | GC, | NA |
| 5355- | AL, | Mini-review: The health benefits and applications of allicin |
| - | Review, | Var, | NA |
| 3542- | ALA, | Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review |
| - | Review, | Var, | NA |
| 3550- | ALA, | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
| - | Review, | AD, | NA |
| 3546- | ALA, | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
| - | Study, | AD, | NA |
| 297- | ALA, | Insights on the Use of α-Lipoic Acid for Therapeutic Purposes |
| - | Review, | BC, | SkBr3 | - | Review, | neuroblastoma, | SK-N-SH | - | Review, | AD, | NA |
| 4132- | Alum, | Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study |
| - | Study, | AD, | NA |
| 1557- | Api, | Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement |
| - | in-vitro, | Nor, | NA |
| 1556- | Api, | Dissolution and antioxidant potential of apigenin self nanoemulsifying drug delivery system (SNEDDS) for oral delivery |
| - | Analysis, | NA, | NA |
| 1554- | Api, | A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota |
| - | Review, | NA, | NA |
| 1551- | Api, | Chemotherapeutic effects of Apigenin in breast cancer: Preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles |
| - | Review, | NA, | NA |
| 1550- | Api, | Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential |
| - | Analysis, | NA, | NA |
| 1540- | Api, | Determination of Total Apigenin in Herbs by Micellar Electrokinetic Chromatography with UV Detection |
| - | Analysis, | NA, | NA |
| 1538- | Api, | Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: In vitro and in vivo evaluations |
| - | in-vivo, | Nor, | NA |
| 1537- | Api, | Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer |
| - | Review, | PC, | NA |
| 1558- | Api, | Preparation, characterization and antitumor activity evaluation of apigenin nanoparticles by the liquid antisolvent precipitation technique |
| - | in-vitro, | Liver, | HepG2 |
| 3822- | Aroma, | Aromatherapy in the treatment of Alzheimer's disease: A systematic review |
| - | Review, | AD, | NA |
| 3391- | ART/DHA, | Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug |
| - | Review, | Var, | NA |
| 557- | ART/DHA, | Artemisinin and Its Derivatives in Cancer Care |
| - | Review, | Var, | NA |
| 2569- | ART/DHA, | A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction |
| - | Human, | Nor, | NA |
| 2577- | ART/DHA, | Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives |
| - | Review, | Var, | NA |
| 5412- | ASA, | Clinical Pharmacology of Aspirin |
| - | Review, | NA, | NA |
| 5400- | ASA, | Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention |
| - | Review, | Nor, | NA |
| 3154- | Ash, | Pharmacokinetics and bioequivalence of Withania somnifera (Ashwagandha) extracts – A double blind, crossover study in healthy adults |
| 5385- | AsP, | GoldNP, | GEM, | Development of ascorbyl palmitate based hydrophobic gold nanoparticles as a nanocarrier system for gemcitabine delivery |
| - | in-vitro, | BC, | NA |
| 5387- | AsP, | PacT, | Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy |
| - | in-vivo, | Melanoma, | B16-F10 |
| 1146- | AsP, | Potential use of nanoformulated ascorbyl palmitate as a promising anticancer agent: First comparative assessment between nano and free forms |
| - | in-vivo, | Nor, | NA |
| 4804- | ASTX, | Astaxanthin in cancer therapy and prevention (Review) |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 4807- | ASTX, | An overview of the anticancer activity of astaxanthin and the associated cellular and molecular mechanisms |
| - | Review, | Var, | NA |
| 5427- | ASTX, | Astaxanthin and Cancer Chemoprevention |
| - | Review, | Var, | NA |
| 5417- | ASTX, | Comparative Pharmacokinetic Study of Standard Astaxanthin and its Micellar Formulation in Healthy Male Volunteers |
| - | Study, | Nor, | NA |
| 5419- | ASTX, | Astaxanthin and other Nutrients from Haematococcus pluvialis—Multifunctional Applications |
| - | Review, | Nor, | NA |
| 5420- | ASTX, | A New Tailored Nanodroplet Carrier of Astaxanthin Can Improve Its Pharmacokinetic Profile and Antioxidant and Anti-Inflammatory Efficacies |
| - | in-vivo, | Nor, | NA |
| - | in-vivo, | Nor, | NA |
| 5423- | ASTX, | Pharmacokinetic Profile of Astaxanthin Nanoemulsion Using HPLC (High-Performance Liquid Chromatography) With Oral Routes |
| - | in-vivo, | Nor, | NA |
| 5364- | AV, | A New Biomaterial Derived from Aloe vera—Acemannan from Basic Studies to Clinical Application |
| - | Review, | Var, | NA |
| 5568- | B-Gluc, | immuno, | Beta-glucans in oncology: revolutionizing treatment with immune power & tumor targeting |
| - | Review, | Var, | NA |
| 5574- | B-Gluc, | Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome |
| - | Review, | Obesity, | NA |
| 5508- | Ba, | Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms |
| - | Review, | Stroke, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 5506- | Ba, | Improved Bioavailability and Hepatoprotective Activity of Baicalein Via a Self-assembled Solutol HS15 Micelles System |
| - | in-vivo, | Nor, | NA |
| 5503- | Ba, | Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes |
| - | Study, | Nor, | NA |
| 5500- | Ba, | Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single‐center, randomized, double‐blind, placebo‐controlled multiple‐ascending‐dose study |
| - | Trial, | Nor, | NA |
| 5496- | Ba, | A strategy to improve the oral availability of baicalein: The baicalein-theophylline cocrystal |
| - | in-vivo, | Nor, | NA |
| 5250- | Ba, | Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid